ATE330609T1 - Ophthalmische zusammensetzung enthaltend antibiotika und nsaids - Google Patents

Ophthalmische zusammensetzung enthaltend antibiotika und nsaids

Info

Publication number
ATE330609T1
ATE330609T1 AT00952254T AT00952254T ATE330609T1 AT E330609 T1 ATE330609 T1 AT E330609T1 AT 00952254 T AT00952254 T AT 00952254T AT 00952254 T AT00952254 T AT 00952254T AT E330609 T1 ATE330609 T1 AT E330609T1
Authority
AT
Austria
Prior art keywords
component
composition
nsaids
composition containing
ophthalmic composition
Prior art date
Application number
AT00952254T
Other languages
English (en)
Inventor
Christopher A Muller
Elizabeth A Bancroft
Janet K Cheetham
Harold G Jensen
Teresa H Kuan
David F Power
Kevin D Skule
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/365,291 external-priority patent/US6166012A/en
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE330609T1 publication Critical patent/ATE330609T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT00952254T 1999-07-30 2000-07-28 Ophthalmische zusammensetzung enthaltend antibiotika und nsaids ATE330609T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36433499A 1999-07-30 1999-07-30
US09/365,291 US6166012A (en) 1999-07-30 1999-07-30 Antibiotic compositions and method for using same

Publications (1)

Publication Number Publication Date
ATE330609T1 true ATE330609T1 (de) 2006-07-15

Family

ID=27002428

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952254T ATE330609T1 (de) 1999-07-30 2000-07-28 Ophthalmische zusammensetzung enthaltend antibiotika und nsaids

Country Status (10)

Country Link
US (4) US6552020B1 (de)
EP (2) EP1688144A1 (de)
JP (1) JP2003505511A (de)
AT (1) ATE330609T1 (de)
AU (1) AU777245B2 (de)
CA (1) CA2388297A1 (de)
DE (1) DE60028978T2 (de)
ES (1) ES2261223T3 (de)
HK (1) HK1046363B (de)
WO (1) WO2001008689A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US20040137079A1 (en) * 2003-01-08 2004-07-15 Cook James N. Contact lens and eye drop rewetter compositions and methods
US20050009836A1 (en) * 2003-06-26 2005-01-13 Laskar Paul A. Ophthalmic composition containing quinolones and method of use
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
US20100130580A1 (en) * 2006-01-25 2010-05-27 Aciex Therapeutics, Inc. Formulations and Methods for Treating Dry Eye
US20070254841A1 (en) * 2006-01-25 2007-11-01 Ophthalmic Research Associates, Inc. Formulations and methods for treating dry eye
WO2008085913A1 (en) * 2007-01-04 2008-07-17 Rib-X Pharmaceuticals, Inc. Methods for treating, preventing, or reducing the risk of opthalmic, otic, and nasal infections
EP2160182A1 (de) * 2007-05-24 2010-03-10 Aciex Therapeutics, Inc. Formulierungen und verfahren zur behandlung von keratoconjunctivitis sicca
WO2009007409A2 (en) * 2007-07-09 2009-01-15 Novagali Pharma Sa Oil in water emulsion comprising nsaids and quaternary ammonium halides
EP2016936B1 (de) * 2007-07-09 2010-09-15 Novagali Pharma S.A. Öl in Wasser Emulsionen enthaltend NSAID und quartär Ammoniumhalogenide
US8512687B2 (en) 2007-07-09 2013-08-20 Novagali Pharma Sa Oil in water emulsion comprising NSAIDs and quaternary ammonium halides
EP2279005A1 (de) * 2008-05-19 2011-02-02 Alcon Research, Ltd. Pharmazeutische zusammensetzungen mit carboxyvinylpolymeren und povidonpolymeren
US8778999B2 (en) * 2009-03-05 2014-07-15 Insite Vision Incorporated Non-steroidal anti-inflammatory ophthalmic compositions
JP5559339B2 (ja) 2009-10-12 2014-07-23 ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング メロキシカムを含む組成物のための容器
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
MX348418B (es) * 2011-10-12 2017-06-12 Bausch & Lomb Composicion ocular que contiene bromfenaco con biodisponibilidad incrementada.
US20160051526A1 (en) * 2013-04-09 2016-02-25 Cresset Biomolecular Discovery Ltd The Local Treatment of Inflammatory Ophthalmic Disorders
US20150164882A1 (en) 2013-07-22 2015-06-18 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en) 2013-07-22 2016-09-29 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
CN103432069A (zh) * 2013-09-12 2013-12-11 安徽环球药业股份有限公司 不含抑菌剂的氧氟沙星滴眼液及其制备方法
US20150335704A1 (en) 2014-05-23 2015-11-26 Imprimis Pharmaceuticals, Inc. Pharmaceutical compositions comprising gels and methods for fabricating thereof
EP3302382A4 (de) * 2015-05-29 2019-02-20 Allergan, Inc. Implantat zur behandlung eines augenleidens
CN105534886A (zh) * 2015-12-31 2016-05-04 湖北远大天天明制药有限公司 一种诺氟沙星滴眼剂及其制备方法
WO2019010447A1 (en) 2017-07-07 2019-01-10 Epicentrx, Inc. COMPOSITIONS FOR PARENTERAL ADMINISTRATION OF THERAPEUTIC AGENTS
IT202000026690A1 (it) * 2020-11-09 2022-05-09 Ntc S R L Composizione oftalmica contenente levofloxacina e ketorolac, metodo di preparazione e suo utilizzo

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
JPS5746986A (en) 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
US4454151A (en) 1982-03-22 1984-06-12 Syntex (U.S.A.) Inc. Use of pyrrolo pyrroles in treatment of ophthalmic diseases
US4551456A (en) 1983-11-14 1985-11-05 Merck & Co., Inc. Ophthalmic use of norfloxacin and related antibiotics
US5414011A (en) 1987-09-11 1995-05-09 Syntex (U.S.A.) Inc. Preservative system for ophthalmic formulations
US5110493A (en) 1987-09-11 1992-05-05 Syntex (U.S.A.) Inc. Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant
DE3906365A1 (de) * 1988-07-15 1990-01-18 Bayer Ag 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
US5360611A (en) 1988-10-03 1994-11-01 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following ultraviolet laser irradiation
US5340572A (en) 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
ES2065846B1 (es) 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
JP2742333B2 (ja) * 1994-05-06 1998-04-22 アルコン ラボラトリーズ，インコーポレイテッド 眼科用組成物におけるビタミンｅトコフェリル誘導体の使用
US5811446A (en) 1997-04-18 1998-09-22 Cytos Pharmaceuticals Llc Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
US6166012A (en) 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same
US6552020B1 (en) * 1999-07-30 2003-04-22 Allergan, Inc. Compositions including antibiotics and methods for using same
EP1586316B1 (de) * 2003-01-21 2008-04-30 Senju Pharmaceutical Co., Ltd. Wässrige flüssige zubereitung mit 2-amino-3-(4-bromobenzoyl)phenylessigsäure

Also Published As

Publication number Publication date
CA2388297A1 (en) 2001-02-08
DE60028978T2 (de) 2007-02-22
WO2001008689A1 (en) 2001-02-08
US6552020B1 (en) 2003-04-22
US6548497B2 (en) 2003-04-15
HK1046363A1 (en) 2003-01-10
AU777245B2 (en) 2004-10-07
HK1046363B (zh) 2006-12-08
JP2003505511A (ja) 2003-02-12
US20010034353A1 (en) 2001-10-25
AU6498500A (en) 2001-02-19
DE60028978D1 (de) 2006-08-03
EP1688144A1 (de) 2006-08-09
ES2261223T3 (es) 2006-11-16
US20030114464A1 (en) 2003-06-19
US20080070908A1 (en) 2008-03-20
EP1200094B1 (de) 2006-06-21
EP1200094A1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
ATE330609T1 (de) Ophthalmische zusammensetzung enthaltend antibiotika und nsaids
DK0771197T3 (da) Anvendelse af heterocykliske forbindelser som dopamin-D3-ligander
AU2001239725A1 (en) Antibacterial agents
CA2299227A1 (en) Synergistic biocide composition
BRPI0415449A (pt) combinações de compostos ativos fungicidas sinergìsticos
AR031478A1 (es) Composiciones antimicrobianas que contienen compuestos de amonio cuaternario, silanos y otros desinfectantes con furanonas
ATE491434T1 (de) Augentropfen enthaltend ketotifen
CA2583037A1 (en) Pouched compositions comprising peracid
EP0513387A4 (en) Active oxygen inhibitor
WO1999032158A3 (en) Aminobiguanides to disinfect contact lenses and preserve pharmaceutical compositions
BR0209317A (pt) Composições incluindo tensoativos com base em vitamina e métodos para usar as mesmas
WO2003090712A3 (en) Compositions for treating hyperemia
BRPI0417175A (pt) composições, método para produzir essas composições, solução que as compreende e métodos para utilizar as mesmas
WO2001007049A3 (en) Ophthalmic composition comprising ketotifen
FI911131A (fi) Menetelmä viherkaihia estävien 3-aryylikarbonyyli-1-aminoalkyyli-1H-indoliyhdisteiden valmistamiseksi
DK0688771T3 (da) Anvendelse af lactamforbindelser som farmaceutiske aktivstoffer
WO2004084626A3 (en) Antimicrobial compositions containing ethanolamine buffer
EP2062872A3 (de) Verwendung von Bisaminen zur Verstärkung der antimikrobiellen Wirkung von wässrigen Zusammensetzungen
ATE239779T1 (de) Bleichmittelzusammensetzungen
CA2025728A1 (en) Antimicrobial compositions
AU740079C (en) Antirheumatic agents
ATE252573T1 (de) 2-aryloxy-4-methyl-6-pyrazol-1-yl-pyridine wirksam als herbizide
FR2770135B1 (fr) Agent bacteriostatique, sa preparation et son utilisation
WO2007002780A3 (en) Topical preservative compositions
AU2234897A (en) Ophthalmologically useful composition, products containing the composition and process for disinfecting and/or cleaning contact lenses

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200094

Country of ref document: EP

REN Ceased due to non-payment of the annual fee